Study of Physiological Signals During and After COPD Exacerbations (DACRE)
Collecte de données Physiologiques en Continu Chez Des Patients en Insuffisance Respiratoire Pendant et après un épisode d'Exacerbation de BPCO
Sponsor: Air de Bretagne
This NA trial investigates COPD and COPD Exacerbation and is currently completed. Air de Bretagne leads this study, which shows 8 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
Status: Unknown → Completed
-
Aug 2024 — Sep 2024 [monthly]
Unknown NA
Status: Recruiting → Unknown
-
Jul 2024 — Aug 2024 [monthly]
Recruiting NA
-
Sep 2022 — Jul 2024 [monthly]
Recruiting NA
-
Feb 2021 — Sep 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
▶ Show 3 earlier versions
-
Jan 2021 — Feb 2021 [monthly]
Not Yet Recruiting NA
-
Aug 2020 — Jan 2021 [monthly]
Not Yet Recruiting NA
-
Aug 2019 — Aug 2020 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Air de Bretagne
- Biosency
- Centre Hospitalier Bretagne Atlantique
- Centre Hospitalier de Saint-Brieuc
- Centre Hospitalier de Saint-Malo
- Rennes University Hospital
- Slb Pharma
For direct contact, visit the study record on ClinicalTrials.gov .